Cortisone reductase deficiency 2

MONDO:0013842

Decreased activity of the enzyme 11-beta-hydroxysteroid dehydrogenase type 1 due to inactivating mutation(s) in the HSD11B1 gene. The condition is characterized by hyperandrogenism as a result of increased adrenocorticotropic hormone stimulation of the adrenal gland due to failure of cortisol-mediated down-regulation, and is clinically indistinguishable from H6PD deficiency.

Also known as: 11-beta-hydroxysteroid dehydrogenase type 1 deficiency, CORTRD2, HSD11B1 cortisone reductase deficiency, cortisone reductase deficiency 2, cortisone reductase deficiency caused by mutation in HSD11B1, cortisone reductase deficiency type 2

41 clinical trials for this condition and its sub-types.

Follow this condition — get notified about new trials

Broader categories

Sort by